Table of Contents Chapter 1 Overview of Point of Care (PoC) Molecular Diagnostics 1.1 Definition of Point of Care (PoC) Molecular Diagnostics in This Report 1.2 Commercial Types of Point of Care (PoC) Molecular Diagnostics 1.2.1 Polymerase Chain Reaction (Real Time PCR) 1.2.2 In Situ Hybridization 1.2.3 Chips and Microarrays 1.2.4 Mass Spectrometry 1.2.5 Sequencing 1.2.6 Isothermal Amplification 1.2.7 Others 1.3 Downstream Application of Point of Care (PoC) Molecular Diagnostics 1.3.1 Hospitals 1.3.2 Diagnostic Laboratories 1.3.3 Research & Academic Laboratories 1.4 Development History of Point of Care (PoC) Molecular Diagnostics 1.5 Market Status and Trend of Point of Care (PoC) Molecular Diagnostics 2013-2023 1.5.1 Europe Point of Care (PoC) Molecular Diagnostics Market Status and Trend 2013-2023 1.5.2 Regional Point of Care (PoC) Molecular Diagnostics Market Status and Trend 2013-2023 Chapter 2 Europe Market Status and Forecast by Regions 2.1 Market Status of Point of Care (PoC) Molecular Diagnostics in Europe 2013-2017 2.2 Consumption Market of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2.2.1 Consumption Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2.2.2 Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2.3 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2.3.1 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Germany 2013-2017 2.3.2 Market Analysis of Point of Care (PoC) Molecular Diagnostics in United Kingdom 2013-2017 2.3.3 Market Analysis of Point of Care (PoC) Molecular Diagnostics in France 2013-2017 2.3.4 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Italy 2013-2017 2.3.5 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Spain 2013-2017 2.3.6 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Benelux 2013-2017 2.3.7 Market Analysis of Point of Care (PoC) Molecular Diagnostics in Russia 2013-2017 2.4 Market Development Forecast of Point of Care (PoC) Molecular Diagnostics in Europe 2018-2023 2.4.1 Market Development Forecast of Point of Care (PoC) Molecular Diagnostics in Europe 2018-2023 2.4.2 Market Development Forecast of Point of Care (PoC) Molecular Diagnostics by Regions 2018-2023 Chapter 3 Europe Market Status and Forecast by Types 3.1 Whole Europe Market Status by Types 3.1.1 Consumption Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Types 3.1.2 Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Types 3.2 Europe Market Status by Types in Major Countries 3.2.1 Market Status by Types in Germany 3.2.2 Market Status by Types in United Kingdom 3.2.3 Market Status by Types in France 3.2.4 Market Status by Types in Italy 3.2.5 Market Status by Types in Spain 3.2.6 Market Status by Types in Benelux 3.2.7 Market Status by Types in Russia 3.3 Market Forecast of Point of Care (PoC) Molecular Diagnostics in Europe by Types Chapter 4 Europe Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Downstream Industry 4.2 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Major Countries 4.2.1 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Germany 4.2.2 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in United Kingdom 4.2.3 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in France 4.2.4 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Italy 4.2.5 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Spain 4.2.6 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Benelux 4.2.7 Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Russia 4.3 Market Forecast of Point of Care (PoC) Molecular Diagnostics in Europe by Downstream Industry Chapter 5 Market Driving Factor Analysis of Point of Care (PoC) Molecular Diagnostics 5.1 Europe Economy Situation and Trend Overview 5.2 Point of Care (PoC) Molecular Diagnostics Downstream Industry Situation and Trend Overview Chapter 6 Point of Care (PoC) Molecular Diagnostics Market Competition Status by Major Players in Europe 6.1 Sales Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Major Players 6.2 Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Major Players 6.3 Basic Information of Point of Care (PoC) Molecular Diagnostics by Major Players 6.3.1 Headquarters Location and Established Time of Point of Care (PoC) Molecular Diagnostics Major Players 6.3.2 Employees and Revenue Level of Point of Care (PoC) Molecular Diagnostics Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Point of Care (PoC) Molecular Diagnostics Major Manufacturers Introduction and Market Data 7.1 Bayer Corporation 7.1.1 Company profile 7.1.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.1.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Corporation 7.2 Roche Diagnostics 7.2.1 Company profile 7.2.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.2.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 7.3 Sysmex Corporation 7.3.1 Company profile 7.3.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.3.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Sysmex Corporation 7.4 Abaxis 7.4.1 Company profile 7.4.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.4.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis 7.5 Abbott Laboratories 7.5.1 Company profile 7.5.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.5.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 7.6 BioMerieux SA 7.6.1 Company profile 7.6.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.6.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA 7.7 Bio-Rad Laboratories 7.7.1 Company profile 7.7.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.7.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories 7.8 Danaher Corporation 7.8.1 Company profile 7.8.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.8.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation 7.9 OraSure Technologies 7.9.1 Company profile 7.9.2 Representative Point of Care (PoC) Molecular Diagnostics Product 7.9.3 Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of OraSure Technologies Chapter 8 Upstream and Downstream Market Analysis of Point of Care (PoC) Molecular Diagnostics 8.1 Industry Chain of Point of Care (PoC) Molecular Diagnostics 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Point of Care (PoC) Molecular Diagnostics 9.1 Cost Structure Analysis of Point of Care (PoC) Molecular Diagnostics 9.2 Raw Materials Cost Analysis of Point of Care (PoC) Molecular Diagnostics 9.3 Labor Cost Analysis of Point of Care (PoC) Molecular Diagnostics 9.4 Manufacturing Expenses Analysis of Point of Care (PoC) Molecular Diagnostics Chapter 10 Marketing Status Analysis of Point of Care (PoC) Molecular Diagnostics 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Polymerase Chain Reaction (Real Time PCR) Table Advantage and Disadvantage of In Situ Hybridization Table Advantage and Disadvantage of Chips and Microarrays Table Advantage and Disadvantage of Mass Spectrometry Table Advantage and Disadvantage of Sequencing Table Advantage and Disadvantage of Isothermal Amplification Table Advantage and Disadvantage of Others Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2013-2017 Table Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2018-2023 Table Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Regions 2018-2023 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Types 2013-2017 Table Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Types 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in Germany 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in United Kingdom 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in France 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in Italy 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in Spain 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in Benelux 2013-2017 Table Consumption Volume of Point of Care (PoC) Molecular Diagnostics by Types in Russia 2013-2017 Table Consumption Volume Forecast of Point of Care (PoC) Molecular Diagnostics in Europe by Types 2018-2023 Table Revenue Forecast of Point of Care (PoC) Molecular Diagnostics in Europe by Types 2018-2023 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Downstream Industry 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Germany 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in United Kingdom 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in France 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Italy 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Spain 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Benelux 2013-2017 Table Demand Volume of Point of Care (PoC) Molecular Diagnostics by Downstream Industry in Russia 2013-2017 Table Demand Volume Forecast of Point of Care (PoC) Molecular Diagnostics in Europe by Downstream Industry 2018-2023 Table Sales Volume of Point of Care (PoC) Molecular Diagnostics in Europe by Major Players 2013-2017 Table Revenue of Point of Care (PoC) Molecular Diagnostics in Europe by Major Players 2013-2017 Table Headquarters Location and Established Time of Point of Care (PoC) Molecular Diagnostics Major Players Table Employees and Revenue Level of Point of Care (PoC) Molecular Diagnostics Major Players Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Bayer Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Bayer Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bayer Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Roche Diagnostics Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Roche Diagnostics Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Sysmex Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Sysmex Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Sysmex Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Abaxis Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Abaxis Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Abbott Laboratories Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Abbott Laboratories Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of BioMerieux SA Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of BioMerieux SA Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Bio-Rad Laboratories Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Bio-Rad Laboratories Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of Danaher Corporation Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of Danaher Corporation Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation 2013-2017 Table Representative Point of Care (PoC) Molecular Diagnostics Product One of OraSure Technologies Table Representative Point of Care (PoC) Molecular Diagnostics Product Two of OraSure Technologies Table Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin of OraSure Technologies 2013-2017